Liz Hockley

Articles by Liz Hockley

Americas

FTC supports USPTO terminal disclaimer plan amid opposition

Proposed change will cut down ‘patent thickets’ says FTC | Biotech firms say changes will damage innovation.   11 July 2024

Careers

Nixon Peabody recruits partner trio from rival for fast-growing IP practice

Firm adds West Coast IP team with expertise across tech and life sciences | New hires include former nationwide IP chair of full-service law firm.   11 July 2024

Biotech

BlueAllele says rival gained $100m from Regeneron deal using patented tech

Minnesota-based biotech firm says Intellia used its patented gene editing innovations | Regeneron paid Intellia $100m for R&D that infringed three patents, alleges BlueAllele.   9 July 2024

Careers

Knobbe Martens partner joins Snell & Wilmer’s Orange County IP practice

New partner has expertise across life sciences, biotech and medtech | Patent attorney spent over 15 years at Knobbe Martens.   4 July 2024

Americas

UK biotech aims at US rival over genome sequencing technology

Biomodal claims New England Biolabs infringed eight patents licensed by US non-profit | Cambridge-based firm produces ‘duet platform’ encompassing genetics and epigenetics.   4 July 2024

Pharma

Report reveals boom in digital health patents

Clarivate analysis identifies 140,000 patented inventions in digital health in decade to 2022 | Patentees comprise a ‘surprising mix’ of companies across various industries.   2 July 2024

Americas

Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic

Judges considered Hikma’s label and marketing material when overturning lower court’s decision | Court said Amarin had stated plausible claim for induced infringement of patents.   27 June 2024

Americas

Eli Lilly takes further action over ‘dangerous’ diabetes drug fakes

US drugmaker files six lawsuits over compounded tirzepatide products | At least five deaths associated with ‘generic’ Mounjaro, according to complaint | Fears over drug's 'unapproved' use for cosmetic weight loss.   25 June 2024

Pharma

High Court says disclosure ‘last resort’ for patent cases in stoma bag dispute

UK judge concludes neither party has ‘won’ in case between Salts and Pelican over ostomy products | Court denied Salts’ request for Model D disclosure.   25 June 2024

Americas

SK Biopharma moves to halt generic versions of epilepsy drug until 2032

South Korean firm has sued two manufacturers in Delaware alleging patent infringement | SKBP asked court to stop ANDAs from Aurobindo and Zenara until patents expire.   19 June 2024

Not finding what you're looking for, please try resetting your applied search and filters,
or try the full site search.